Blog

In 2017, Yale researchers conducted a study to investigate unexplained hypophosphatemia in children. The results showed that children who were switched from Neocate to an alternative source of nutrition immediately saw improved levels of calcium and phosphate and eventual improvement in skeletal development. The Method This study was a retrospective chart review conducted in North America…

On July 13, 2018, the FDA issued a recall of Valsartan, a drug prescribed to treat high blood pressure, after it was found to contain a carcinogen called N-nitrosodimethylamine (NDMA). Valsartan has been approved as a treatment for high blood pressure in adults and children age six and up. It is also approved for adults…

The first transvaginal mesh entered the market in 1996 when Boston Scientific released its ProteGen bladder sling to help women suffering from stress urinary incontinence (SUI) and pelvic organ prolapse (POP). The product was recalled in 1999 after reports of complications with the mesh. What Is the Problem? Boston Scientific was able to fast-track…

Goldenberg Lauricella would like to congratulate our Partners for being recognized for their outstanding work. Senior Partner Stuart Goldenberg was selected to the 2018 Minnesota Super Lawyers list. This is Stuart’s 16th consecutive year being included on this list. Partners Laura Pittner and Marlene Goldenberg are 2018 Minnesota Rising Stars list honorees. This is their fourth consecutive year on the list….

Neocate, an amino-acid-based baby formula, is linked to hypophosphatemia, or low levels of phosphates, and hypocalcemia, or low calcium levels. These conditions can cause severe injuries in children and babies, including: Spontaneous or unexplained bone fractures Bone pain Broken bones Stunted growth and development Rickets (vitamin D deficiencies) Many infants and children take Neocate…

Plaintiffs in the ongoing St. Louis Johnson & Johnson talcum powder trial have alleged that J&J secretly funded research that concluded talcum powder does not cause ovarian cancer. The research was conducted by researchers retained by Crowell & Moring LLP, a law firm also retained by Luzenac, now known as Imerys. Imerys is J&J’s…